July 10, 2024 - We are pleased to announce Robert Shaffer, assistant deputy minister at the Department of Health in Manitoba, has assumed the role of chair of the Board for the pCPA. Pam Barnes, director of Drug Programs and Services for the Government of Newfoundland and Labrador, is stepping into the role of vice-chair.
July 8, 2024 - The pCPA is pleased to announce that Dr. Clifford Lo will be joining the pCPA team as acting deputy CEO.
Effective May 10, 2024, Dominic Tan has assumed the responsibilities of CEO of the pCPA on an interim basis.
April 5, 2024 - Following consultations with stakeholders in the late summer and early fall of 2023, we have finalized the principles and conditions for the new pCPA Temporary Access Process (pTAP).
As of May 1, 2024, changes to the market exit process for generic drugs are in effect.
December 7, 2023 – In August 2023, the pCPA engaged with clinicians, patient groups and industry to present and hear feedback on a set of principles and conditions for a pCPA Temporary Access Process (pTAP).
October 26, 2023 – The pCPA Board of Directors is thrilled to release the organization’s inaugural report, a report that is a testament to the transformative nature of this past year.
The pan-Canadian Pharmaceutical Alliance Corporation (pCPA) Annual General Meeting
To be held at 2125 Victoria Avenue, Regina, SK. S4P 0S3 on October 25, 2023 at 5 p.m. CST
Notice is hereby given that the first Annual General Meeting of the members of the pan-Canadian Pharmaceutical Alliance Corporation (pCPA) will take place on Wednesday, October 25, 2023 at 5 p.m. CST. Members may participate in person or virtually.
The new three-year pricing initiative for generic drugs will come into effect on October 1, 2023.
The agreement between the pan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) builds upon the successes achieved to date with the pan-Canadian Generic Tiered Pricing Framework (TPF) and the pan-Canadian molecules.
The pan-Canadian Pharmaceutical Alliance’s (pCPA) Board of Directors is excited to announce that Douglas Clark will become the first CEO of the newly incorporated organization, effective September 11, 2023.